AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
AGRZ

Agroz Inc. Ordinary Shares (AGRZ) fair value

Consumer Defensive · Farm Products · NASDAQ · United States
$2.89-1.37%
Market cap $5MUpdated Oct 24, 2026
Our verdict
Trades 86% below our fair value
Price
$2.89
Model fair valueConfidence: low
about $21.20
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a growth company: EV/EBITDA comparison.
ACCE opinionAgroz Inc. Ordinary Shares (AGRZ)
Fair value
Not available
ACCE price target
$3.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 20 Oct 2026, 02:20 CEST; previously $3.90 since 15 Oct 2026, 00:00 CEST.
Price used: $2.89 at the close on 23 Oct 2026, 22:00 CEST.
Models: EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
62
out of 100
P/E
1.9x
1-year return
-41.9%
Dividend yield
0.00%

Agroz Inc. Ordinary Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Agroz Inc. is a micro-cap farm products company with a $5M market cap, and the numbers you have to test are unusual: 30.7% revenue growth, a 29.9% gross margin, a 19.6% operating margin, and a 26.7% ROE alongside a trailing P/E of 2.0. Those figures look too good to be true for a company this small, which is exactly why the thesis needs verifying before anyone spends time on it. The data provided does not name specific products, end markets or a catalyst, so the operating driver behind the growth is unknown from this screen. A forward P/E of 0.0 suggests no reliable earnings estimates exist, and the stock sits in no index. The case for a deeper look rests entirely on whether the reported margins and earnings are real and durable, which the filings and the company's disclosures would need to establish.

AI-assisted·How I use AIWritten Oct 18, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where AGRZ's valuation models land
Price
$2.89
Model fair valueConfidence: low
about $21.20
Model
Fair value
Upside
EV/EBITDA comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+1.8%
1 month
-40.5%
3 months
-52.6%
6 months
+622.5%
YTD
+275.3%
1 year
-41.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 02:20 CESTACCE price target$3.00$3.90$2.72
15 Oct 2026, 00:00 CESTACCE price target$3.90first publication$3.76

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full AGRZ page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value59Quality78Momentum46Total62
Valuation
Trailing P/E
1.9x
Forward P/E
no data
PEG
no data
P/B
1.31x
EV / Revenue
0.4x
Book value/sh
MYR 7.91
Enterprise value
$6M
Profitability
ROE
26.7%
FCF yield
-27.02%
ROIC
14.0%
Health and risk
Debt / equity
0.37
Dividend yield
0.00%
Beta
no data

Price

-42.5% · 1Y

Ask anything about AGRZ

Answered from Agroz Inc. Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 25% of peers
low 0.0x1.9xhigh 2.3x
ROEbetter than 83% of peers
low -393%27%high 28%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
AGRZ Agroz Inc. Ordinary Shares$2.89--1.9x26.7%7862
AQB AquaBounty Technologies Inc. Common Stock$1.11----50.2%1326
PVA.MC Pescanova, S.A.€0.22---1.4%3229
TULP Bloomia Holdings Inc. Common Stock$2.40----93.5%2220
ALAGR.PA AgroGeneration SA€0.05--2.3x27.9%7455
SDOT Sadot Group Inc. Common Stock$7.00----392.8%1337
ALKKO.PA KKO International SA€0.06---0.9%4742

Sector report card

Where AGRZ ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Sep 24, 2026
    AGROZ INC. ANNOUNCES ANTICIPATED REVERSE STOCK SPLIT
  • PR Newswire•Sep 9, 2026
    AGROZ INC. ENTERS INTO STRATEGIC SUPPLY AGREEMENT WITH HARVEST HIVE
  • PR Newswire•Sep 4, 2026
    Agroz Strengthens Global Position with Series of Prestigious International Awards and Industry Recognitions
11 more press releases · full archive on Investor+.INVESTOR
14 filings of 16
September 2026
Sep 28
20-FForeign annualPeriod 2025-12-31
View on SEC →
Sep 3
6-KForeign current reportPeriod 2026-09-03
View on SEC →
June 2026
Jun 30
6-KForeign current reportPeriod 2026-06-30
View on SEC →
11 more filings + AI summaries on Investor+.INVESTOR